The company said that analyses and modeling of mutations in the variant suggest that they may weaken the effect of the treatment, but that studies using Omicron’s full sequences are incomplete.
from NYT > Health https://ift.tt/3o5VL8d
via health&fitness
Aucun commentaire:
Enregistrer un commentaire